Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.80 |
| ▸ | CES2 | O00748 | 5/20 | 0.80 |
| ▸ | HPGD | P15428 | 4/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.80 |
| ▸ | BLM | P54132 | 3/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.80 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.80 |
| ▸ | IDO1 | P14902 | 3/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.61 |
| ▸ | EPAS1 | Q99814 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CES1 | P23141 | 3/20 | 0.61 |
| ▸ | EED | O75530 | 3/20 | 0.61 |
| ▸ | SUZ12 | Q15022 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14417881 | 0.89 | MEN1 (0.80) | MEN1ALDH1A1KMT2ACES2HPGD | |
| Tanshinone Iia Sulfonic Acid SCHEMBL28665868 | 0.88 | MEN1 (1.00) | MEN1ALDH1A1KMT2ACES2HPGD | |
| Tanshinone Iia Sulfonic Acid SCHEMBL30094475 | 0.88 | MEN1 (1.00) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL28841602 | 0.81 | MEN1 (0.63) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL14417878 | 0.80 | MEN1 (0.67) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL14417741 | 0.80 | MEN1 (0.67) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL28411969 | 0.80 | MEN1 (0.67) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL14417875 | 0.80 | MEN1 (0.66) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL14417882 | 0.79 | MEN1 (0.65) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL28128354 | 0.78 | MEN1 (0.59) | MEN1ALDH1A1KMT2ACES2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119185650-A | Preparation method of prefilled needle with rapid and long-term anti-inflammatory, analgesic and tissue repair promoting effects | 东方妍美(成都)生物技术有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-113679726-B | Application of red sage root extract and quinone compound in resisting coronavirus | 上海科技大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-119185650-A | Preparation method of prefilled needle with rapid and long-term anti-inflammatory, analgesic and tissue repair promoting effects | 东方妍美(成都)生物技术有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119185650-A | Preparation method of prefilled needle with rapid and long-term anti-inflammatory, analgesic and tissue repair promoting effects | 东方妍美(成都)生物技术有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-118021812-A | Nidaminib targeting compositions | 北京睿创康泰医药研究院有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-112625010-B | 9-hydroxy phenanthrenequinone derivative and preparation method and application thereof | 中山大学 | 2023-03-03 | — | — | CN | disclosed |
| US-20180021303-A1 | BKCA CHANNEL ACTIVATOR FOR TREATING MUSCULAR DISORDER | CANBEX THERAPEUTICS LTD (GB) | 2018-01-25 | — | — | US | disclosed |
| US-9771343-B2 | 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2017-09-26 | — | — | US | disclosed |
| US-9771343-B2 | 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2017-09-26 | — | — | US | disclosed |
| US-9328083-B2 | 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2016-05-03 | — | — | US | disclosed |
| US-9328083-B2 | 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2016-05-03 | — | — | US | disclosed |
| US-20150126552-A1 | 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2015-05-07 | — | — | US | disclosed |
| US-20150126552-A1 | 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2015-05-07 | — | — | US | disclosed |
| US-20140336249-A1 | 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2014-11-13 | — | — | US | disclosed |
| US-20140336249-A1 | 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2014-11-13 | — | — | US | disclosed |
| EP-2786989-A1 | 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) | 2014-10-08 | — | — | EP | disclosed |
| EP-2786990-A1 | 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) | 2014-10-08 | — | — | EP | disclosed |
| US-20070207989-A1 | DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES | SAVIPU PHARMACEUTICALS (US) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126552-A1 | 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | NQO1, NFE2L2, NOS2 | MEN1 977/4885ALDH1A1 94/4885KMT2A 853/4885 |
| US-20070207989-A1 | DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES | NFKBIA, EDNRA, EDNRB | MEN1 3639/4885ALDH1A1 2108/4885KMT2A 4424/4885 |
| US-20180021303-A1 | BKCA CHANNEL ACTIVATOR FOR TREATING MUSCULAR DISORDER | KCNMA1, KCNMB1, KCNA1 | MEN1 2510/4885ALDH1A1 4618/4885KMT2A 176/4885 |
| US-20140336249-A1 | 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF | CYP2A7, TBXAS1, CYP2J2 | MEN1 2512/4885ALDH1A1 750/4885KMT2A 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.